Cybin Inc. (NEO:CYBN)
Canada · Delayed Price · Currency is CAD 9.20
-0.35 (-3.66%)
Aug 19, 2025, 3:42 PM EDT
Cybin Employees
Cybin had 50 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-2.64M CAD
Market Cap
215.41M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 50 | 0 | - |
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Curaleaf Holdings | 5,519 |
| Green Thumb Industries | 4,800 |
| Trulieve Cannabis | 6,000 |
| Sienna Senior Living | 12,263 |
| dentalcorp Holdings | 10,200 |
| Cronos Group | 459 |
| WELL Health Technologies | 1,507 |
| Extendicare | 23,000 |
Cybin News
- 1 day ago - Cybin Announces Results of Annual Meeting of Shareholders - Business Wire
- 5 days ago - Cybin reports Q1 results - Seeking Alpha
- 6 days ago - Cybin Reports Important Progress on Key Milestones and First Quarter Fiscal Year 2026 Financial Results - Business Wire
- 12 days ago - Cybin Receives European Approval for EMBRACE, a Multinational Phase 3 Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder - Financial Post
- 12 days ago - Cybin Receives European Approval for EMBRACE, a Multinational Phase 3 Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder - Business Wire
- 13 days ago - Cybin to Participate in the Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 4 weeks ago - Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder - Business Wire
- 7 weeks ago - REPEAT/Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures - Business Wire